Efficacy of injectable trivalent virosomal-adjuvanted inactivated influenza vaccine in preventing acute otitis media in children with recurrent complicated or noncomplicated acute otitis media

Pediatric Infectious Disease Journal

Volumn 28, Issue 10, 2009, Pages 855-859

  Marchisio, Paola ^a   Esposito, Susanna ^a   Bianchini, Sonia ^a   Dusi, Elisa ^a   Fusi, Michela ^a   Nazzari, Erica ^a   Picchi, Raffaella ^a   Galeone, Carlotta ^b   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Acute otitis media; Children; Influenza; Influenza vaccination; Recurrent acute otitis media; Vaccine

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; INACTIVATED VIROSOMAL ADJUVANTED INFLUENZA VACCINE; INFLUENZA VACCINE; PLACEBO; UNCLASSIFIED DRUG;

ACUTE OTITIS MEDIA; ARTICLE; CHILD; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DECREASED APPETITE; DISEASE COURSE; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; EARDRUM PERFORATION; FEMALE; FEVER; HUMAN; INFANT; INFLUENZA; INJECTION; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PATIENT MONITORING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; RHINITIS; SIDE EFFECT; SINGLE BLIND PROCEDURE; SKIN REDNESS; SWELLING; TREATMENT DURATION; TREATMENT OUTCOME; VACCINATION; VOMITING;

EID: 70349706256     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181a487b4     Document Type: Article

References (37)

1. Paradise JL, Rockette HE, Colborn DK, et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics. 1997;99:318-333.
2. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics. 2004;113:1451-1465.
3. Gravel JS, Karma P, Casselbrant ML, et al. Recent advances in otitis media. Diagnosis and screening. Ann Otol Rhinol Laryngol Suppl. 2005;194: 104-113.
4. Leach AJ, Morris PS. Antibiotics for the prevention of acute and chronic suppurative otitis media in children. Cochrane Database Syst Rev. 2006; CD004401.
5. Rosenfeld RM, Lous J, Bluestone CD, et al. Recent advances in otitis media. Treatment. Ann Otol Rhinol Laryngol Suppl. 2005;194:114-139.
6. Meropol SB. Valuing reduced antibiotic use for pediatric acute otitis media. Pediatrics. 2008;121:669-673.
7. Fliss DM, Leiberman A, Dagan R. Medical sequelae and complications of acute otitis media. Pediatr Infect Dis J. 1994;13(1 suppl 1):S34-S40.
8. Cripps AW, Otczyk DC. Prospects for a vaccine against otitis media. Expert Rev Vaccines. 2006;5:517-534.
9. Sox CM, Finkelstein JA, Yin R, et al. Trends in otitis media treatment failure and relapse. Pediatrics. 2008;121:674-679.
10. Klein JO. Otitis media. Clin Infect Dis. 1994;19:823-833.
11. Leibovitz E. The challenge of recalcitrant acute otitis media: pathogens, resistance, and treatment strategy. Pediatr Infect Dis J. 2007;26(suppl. 10):S8-S11.
12. Barenkamp SJ, Kurono Y, Ogra PL, et al. Recent advances in otitis media. 5. Microbiology and immunology. Ann Otol Rhinol Laryngol Suppl. 2005; 194:60-85.
13. Bulut Y, Guven M, Otlu B, et al. Acute otitis media and respiratory viruses. Eur J Pediatr. 2007;166:223-228.
14. Revai K, Dobbs LA, Nair S, et al. Incidence of acute otitis media and sinusitis complicating upper respiratory tract infection: the effect of age. Pediatrics. 2007;119:e1408-e1412.
15. Chonmaitree T, Reval K, Grady JJ, et al. Viral upper respiratory infection and otitis media complication in young children. Clin Infect Dis. 2008;46: 815-823.
16. Barnett ED. Influenza immunization in children. N Engl J Med. 1998;338: 1459-1461.
17. Heikkinen T. The role of respiratory viruses in otitis media. Vaccine. 2000;19(suppl 1):S51-S55. (Pubitemid 32121720)
18. Giebink GS, Kurono Y, Bakaletz LO, et al. Recent advances in otitis media. 6. Vaccine. Ann Otol Rhinol Laryngol Suppl. 2005;194:86-103.
19. Bosis S, Esposito S, Niesters HG, et al. Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses. J Med Virol. 2005;75:101-104.
20. Esposito S, Gasparini R, Bosis S, et al. Clinical and socioeconomic impact of influenza and respiratory syncytial virus (RSV) infection on healthy children and their households. Clin Microbiol Infect. 2005;11:933-936.
21. Principi N, Esposito S. Are we ready for universal influenza vaccination in paediatrics? Lancet Infect Dis. 2004;4:75-83.
22. Principi N, Esposito S. Prevention or control of influenza in the pediatric population. Emerg Infect Dis. 2004;10:574-580.
23. Heikkinen T, Ruuskanen O, Waris M, et al. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child. 1991;145: 445-448.
24. Clements DA, Langdom L, Bland C, et al. Influenza A vaccine decreases incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med. 1995;149:1113-1117.
25. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med. 1998;338:1405-1412.
26. Hurwitz ES, Haber M, Chang A, et al. Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infections, and clinical effectiveness. J Infect Dis. 2000;182:1218-1223.
27. Jansen AG, Sanders EA, Hoes AW, et al. Effects of influenza plus pneumococcal conjugate vaccination versus influenza vaccination alone in preventing respiratory tract infections in children: a randomized, doubleblind, placebo-controlled trial. J Pediatr. 2008;153:764-770.
28. Manzoli L, Schioppa F, Boccia A, et al. The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality. Pediatr Infect Dis J. 2007;26:97-106.
29. Hoberman A, Greenberg DP, Paradise JL, et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA. 2003;290:1608-1616.
30. Marchisio P, Cavagna R, Maspes B, et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clin Infect Dis. 2002;35:168-174.
31. Segal N, Givon-Lavi N, Leibovitz E, et al. Acute otitis media caused by Streptococcus pyogenes in children. Clin Infect Dis. 2005;41:35-41.
32. Peltola VT, Murti GK, McCullers JA. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis. 2005;192:249-257.
33. Van der Sluijs KF, Nijhuis M, Levels JHM, et al. Influenza-induced expression of indolamine 2,3-dioxigenase enhances interleukin-10 production and bacterial outgrowth during secondary pneumonia. J Infect Dis. 2006;193:214-222.
34. Pichichero ME, Casey JR. Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era. Pediatr Infect Dis J. 2007;26(10 suppl):S12-S16.
35. Rovers MM, Numans ME, Langenbach E, et al. Is pacifier use a risk factor for acute otitis media? A dynamic cohort study. Fam Pract. 2008;25:233-236.
36. Esposito S, Marchisio P, Bosis S, et al. Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years. Vaccine. 2006; 24:629-635.
37. Esposito S, Gasparini C, Martelli A, et al. Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy. Vaccine. 2008;26:4664-4668.